{"hands_on_practices": [{"introduction": "The specificity of Fluorescence In Situ Hybridization (FISH) and Spectral Karyotyping (SKY) hinges on designing DNA probes that bind uniquely to their intended chromosomal targets. This exercise explores the probabilistic foundation of probe design, challenging you to calculate the minimum probe length required to be statistically unique within the entire human genome. By working through this problem, you will gain a quantitative appreciation for the principles that ensure these powerful diagnostic tools are both accurate and reliable.", "problem": "In medical genetics, Fluorescence In Situ Hybridization (FISH) and Spectral Karyotyping (SKY) employ short, single-stranded deoxyribonucleic acid (DNA) oligonucleotide probes that hybridize to complementary genomic loci. To minimize cross-hybridization and ensure locus specificity, the probe should be long enough that, under a random-sequence model, the probability that it perfectly matches any unintended locus in the human genome is acceptably small.\n\nAssume the following foundational model:\n- The haploid human genome length is $G = 3.2 \\times 10^{9}$ base pairs.\n- Genomic bases are independently and identically distributed with equal frequency for adenine, cytosine, guanine, and thymine, so that the probability that a random base equals a specified base is $1/4$.\n- A probe of length $L$ nucleotides binds only by perfect complementary matching.\n- Scanning the genome for possible perfect matches corresponds to examining approximately $G - L + 1 \\approx G$ distinct starting positions; each position independently matches the probe sequence with probability $(1/4)^{L}$.\n- There is exactly one true intended target locus; all other matches, if any, are considered false bindings.\n\nUsing these assumptions and standard rare-event approximations from probability theory, determine the minimal integer probe length $L$ (in nucleotides) such that the probability of at least one unintended perfect match anywhere else in the genome is at most $10^{-6}$. Report the minimal integer $L \\in \\mathbb{N}$ that satisfies this bound. Do not round to a prescribed number of significant figures; instead, return the smallest integer length that achieves the stated probability criterion.", "solution": "The user wants me to solve a problem from medical genetics.\n\n### Step 1: Validation\nI will first validate the problem statement.\n\n#### Extracted Givens\n- Haploid human genome length: $G = 3.2 \\times 10^{9}$ base pairs.\n- Genomic bases are independently and identically distributed with equal frequency for adenine ($A$), cytosine ($C$), guanine ($G$), and thymine ($T$).\n- Probability that a random base equals a specified base: $\\frac{1}{4}$.\n- Probe length: $L$ nucleotides.\n- Binding condition: perfect complementary matching.\n- Number of positions to scan for matches is approximately $G - L + 1 \\approx G$.\n- Probability of a perfect match at a single position is $(\\frac{1}{4})^{L}$.\n- Number of true intended target loci: $1$. All other matches are false.\n- The probability of at least one unintended perfect match must be at most $10^{-6}$.\n- Objective: Find the minimal integer probe length $L \\in \\mathbb{N}$.\n\n#### Validation Assessment\n- **Scientifically Grounded:** The problem uses a simplified but standard first-order model for calculating probe specificity. This model is a cornerstone of molecular biology and bioinformatics for designing primers and probes. The values used are standard. The problem is scientifically sound.\n- **Well-Posed:** All necessary parameters ($G$, probability model, target probability) are provided. The objective is to find a minimal integer $L$ satisfying a clear inequality. A unique solution is expected.\n- **Objective:** The language is formal and precise, with no subjective content.\n- **Other Flaws:** The problem is free from the flaws listed in the instructions (e.g., it is not contradictory, infeasible, or trivial). The explicit mention of a \"rare-event approximation\" and the approximation $G - L + 1 \\approx G$ are standard and valid in this context, making the problem well-structured for a solution.\n\n#### Verdict\nThe problem is valid. I will proceed with the solution.\n\n### Step 2: Solution\nThe problem requires finding the minimal integer probe length, $L$, such that the probability of observing at least one unintended perfect match in the genome is at most $10^{-6}$.\n\nLet $N$ be the random variable for the number of unintended perfect matches. The total length of the haploid genome is $G = 3.2 \\times 10^{9}$ base pairs. A probe of length $L$ can potentially start at any of the first $G-L+1$ positions. Since one of these positions is the intended target, the number of unintended loci to consider is $n = (G-L+1) - 1 = G-L$. Given that $G \\gg L$, we can approximate this number as $n \\approx G$. The problem statement assumes approximately $G$ independent trials. To be slightly more precise, let's consider the number of unintended sites to be $n=G-1$, which is also excellently approximated by $G$.\n\nAt each unintended locus, the probability of a perfect match, $p$, is given by the probability of matching each of the $L$ bases independently. With four equally likely bases, this probability is:\n$$ p = \\left(\\frac{1}{4}\\right)^{L} = 4^{-L} $$\n\nThe number of unintended matches, $N$, follows a binomial distribution, $N \\sim \\text{Binomial}(n, p)$, where $n \\approx G$ is the number of trials and $p$ is the success probability per trial. Since $n$ is very large (on the order of $10^9$) and $p$ is very small, we can use the Poisson approximation, as suggested by the problem's reference to \"rare-event approximations.\" The distribution of $N$ is well-approximated by a Poisson distribution with parameter $\\lambda = np$.\n$$ \\lambda = n \\cdot p \\approx G \\cdot p = (3.2 \\times 10^{9}) \\cdot 4^{-L} $$\n\nThe problem specifies the constraint on the probability of at least one unintended match:\n$$ P(N \\geq 1) \\leq 10^{-6} $$\n\nFor a Poisson-distributed variable, the probability of observing at least one event is $P(N \\geq 1) = 1 - P(N=0)$. The probability of zero events is $P(N=0) = \\frac{e^{-\\lambda}\\lambda^0}{0!} = e^{-\\lambda}$. Substituting this into the inequality gives:\n$$ 1 - e^{-\\lambda} \\leq 10^{-6} $$\n\nFor a very small upper bound on probability, such as $10^{-6}$, the expression $1 - e^{-\\lambda}$ can be approximated by $\\lambda$. This comes from the Taylor expansion $e^{-\\lambda} \\approx 1 - \\lambda$ for small $\\lambda$, which makes $1 - e^{-\\lambda} \\approx 1 - (1 - \\lambda) = \\lambda$. Thus, the condition simplifies to a constraint on the Poisson parameter $\\lambda$:\n$$ \\lambda \\leq 10^{-6} $$\n\nNow, we substitute the expression for $\\lambda$ in terms of $L$:\n$$ (3.2 \\times 10^{9}) \\cdot 4^{-L} \\leq 10^{-6} $$\n\nWe can now solve this inequality for $L$. First, we isolate the term containing $L$:\n$$ 4^{-L} \\leq \\frac{10^{-6}}{3.2 \\times 10^{9}} $$\nTaking the reciprocal of both sides reverses the inequality sign:\n$$ 4^{L} \\geq \\frac{3.2 \\times 10^{9}}{10^{-6}} $$\n$$ 4^{L} \\geq 3.2 \\times 10^{15} $$\n\nTo solve for $L$, we take the natural logarithm of both sides:\n$$ \\ln(4^{L}) \\geq \\ln(3.2 \\times 10^{15}) $$\nUsing the logarithm property $\\ln(a^b) = b \\ln(a)$:\n$$ L \\ln(4) \\geq \\ln(3.2) + \\ln(10^{15}) $$\n$$ L \\cdot (2 \\ln(2)) \\geq \\ln(3.2) + 15 \\ln(10) $$\nIsolating $L$ gives:\n$$ L \\geq \\frac{\\ln(3.2) + 15 \\ln(10)}{2 \\ln(2)} $$\n\nBy substituting the numerical values of the logarithms ($\\ln(2) \\approx 0.69315$, $\\ln(10) \\approx 2.30259$, $\\ln(3.2) \\approx 1.16315$):\n$$ L \\geq \\frac{1.16315 + 15(2.30259)}{2(0.69315)} $$\n$$ L \\geq \\frac{1.16315 + 34.53885}{1.3863} $$\n$$ L \\geq \\frac{35.702}{1.3863} $$\n$$ L \\geq 25.7529... $$\n\nSince the probe length $L$ must be an integer, we must choose the smallest integer that satisfies this condition. Therefore, the minimal integer length is $26$.", "answer": "$$\\boxed{26}$$", "id": "5031342"}, {"introduction": "Spectral Karyotyping (SKY) achieves its power by painting each chromosome with a unique combination of fluorophores, creating a distinct spectral \"signature.\" This practice delves into the computational heart of SKY, modeling the measured light at a single pixel as a linear combination of basis spectra from each fluorophore. By solving a least-squares problem, you will perform spectral unmixing to determine the contribution of each fluorophore, gaining insight into how complex color information is computationally decoded.", "problem": "In Fluorescence In Situ Hybridization (FISH) and Spectral Karyotyping (SKY), a single pixelâ€™s measured spectrum across multiple detector channels is modeled as a linear superposition of fluorophore emission basis spectra, assuming additive photon counts and independent Gaussian measurement noise. This linear superposition arises because, under typical imaging conditions, emitted photons from different fluorophores are collected by the detector in a way that adds their contributions in each spectral channel. Let the measured spectrum be the vector $\\mathbf{y} \\in \\mathbb{R}^{m}$, the reference (basis) spectra be the columns of the matrix $\\mathbf{R} \\in \\mathbb{R}^{m \\times n}$, and the unknown fluorophore contributions be the vector $\\mathbf{x} \\in \\mathbb{R}^{n}$. The model is $\\mathbf{y} = \\mathbf{R}\\mathbf{x} + \\mathbf{e}$, where $\\mathbf{e}$ is a noise vector.\n\nFor a SKY imaging system with $m=5$ spectral channels and $n=3$ fluorophores (approximating, for instance, the contributions of fluorescein isothiocyanate, cyanine 3, and cyanine 5), consider the following experimentally measured pixel spectrum and reference matrix:\n$$\n\\mathbf{y} = \\begin{pmatrix}31 \\\\ 49 \\\\ 37 \\\\ 28 \\\\ 18\\end{pmatrix}, \\quad\n\\mathbf{R} = \\begin{pmatrix}\n8  2  0 \\\\\n7  6  1 \\\\\n2  7  3 \\\\\n1  2  8 \\\\\n0  1  7\n\\end{pmatrix}.\n$$\nAssume the linear model described above and that the most likely $\\mathbf{x}$ under independent Gaussian noise is obtained by minimizing the squared Euclidean norm of the residual, that is, by minimizing $||\\mathbf{y} - \\mathbf{R}\\mathbf{x}||_{2}^{2}$.\n\nTasks:\n- Starting from the least-squares criterion $||\\mathbf{y} - \\mathbf{R}\\mathbf{x}||_{2}^{2}$, derive the condition that characterizes the minimizer and solve for the unmixing coefficients $\\hat{\\mathbf{x}}$ using the provided $\\mathbf{R}$ and $\\mathbf{y}$.\n- Compute the residual vector $\\mathbf{r} = \\mathbf{y} - \\mathbf{R}\\hat{\\mathbf{x}}$ and its Euclidean norm $||\\mathbf{r}||_{2}$.\n- Briefly reason whether the magnitude of $||\\mathbf{r}||_{2}$ relative to $||\\mathbf{y}||_{2}$, together with the column correlations in $\\mathbf{R}$, suggests a potential need for regularization in the unmixing.\n\nAnswer specification:\n- Report only the Euclidean norm $||\\mathbf{r}||_{2}$.\n- Express the final norm in counts.\n- Round your answer to four significant figures.", "solution": "The problem requires finding the unmixing coefficients for a spectral imaging system by solving a linear least-squares problem, and then analyzing the resulting residual.\n\nThe model is given by the linear equation $\\mathbf{y} = \\mathbf{R}\\mathbf{x} + \\mathbf{e}$, where $\\mathbf{y} \\in \\mathbb{R}^{m}$ is the measured spectrum, $\\mathbf{R} \\in \\mathbb{R}^{m \\times n}$ contains the reference spectra of the fluorophores, $\\mathbf{x} \\in \\mathbb{R}^{n}$ represents the unknown contributions of these fluorophores, and $\\mathbf{e}$ is a noise vector. We are given $m=5$ and $n=3$.\n\nThe specific data are:\n$$\n\\mathbf{y} = \\begin{pmatrix}31 \\\\ 49 \\\\ 37 \\\\ 28 \\\\ 18\\end{pmatrix}, \\quad\n\\mathbf{R} = \\begin{pmatrix}\n8  2  0 \\\\\n7  6  1 \\\\\n2  7  3 \\\\\n1  2  8 \\\\\n0  1  7\n\\end{pmatrix}\n$$\n\nThe first task is to derive the condition for the minimizer of the least-squares criterion $J(\\mathbf{x}) = ||\\mathbf{y} - \\mathbf{R}\\mathbf{x}||_{2}^{2}$.\nWe expand the squared Euclidean norm:\n$$\nJ(\\mathbf{x}) = (\\mathbf{y} - \\mathbf{R}\\mathbf{x})^{T}(\\mathbf{y} - \\mathbf{R}\\mathbf{x}) = (\\mathbf{y}^{T} - \\mathbf{x}^{T}\\mathbf{R}^{T})(\\mathbf{y} - \\mathbf{R}\\mathbf{x})\n$$\n$$\nJ(\\mathbf{x}) = \\mathbf{y}^{T}\\mathbf{y} - \\mathbf{y}^{T}\\mathbf{R}\\mathbf{x} - \\mathbf{x}^{T}\\mathbf{R}^{T}\\mathbf{y} + \\mathbf{x}^{T}\\mathbf{R}^{T}\\mathbf{R}\\mathbf{x}\n$$\nSince $\\mathbf{x}^{T}\\mathbf{R}^{T}\\mathbf{y}$ is a scalar, it is equal to its transpose, $(\\mathbf{x}^{T}\\mathbf{R}^{T}\\mathbf{y})^{T} = \\mathbf{y}^{T}\\mathbf{R}\\mathbf{x}$. Thus, the objective function can be written as:\n$$\nJ(\\mathbf{x}) = \\mathbf{y}^{T}\\mathbf{y} - 2\\mathbf{x}^{T}\\mathbf{R}^{T}\\mathbf{y} + \\mathbf{x}^{T}\\mathbf{R}^{T}\\mathbf{R}\\mathbf{x}\n$$\nTo find the minimum, we compute the gradient of $J(\\mathbf{x})$ with respect to $\\mathbf{x}$ and set it to the zero vector. Using standard matrix calculus identities, $\\nabla_{\\mathbf{x}}(\\mathbf{x}^{T}\\mathbf{b}) = \\mathbf{b}$ and $\\nabla_{\\mathbf{x}}(\\mathbf{x}^{T}\\mathbf{A}\\mathbf{x}) = 2\\mathbf{A}\\mathbf{x}$ for a symmetric matrix $\\mathbf{A}$, we get:\n$$\n\\nabla_{\\mathbf{x}} J(\\mathbf{x}) = -2\\mathbf{R}^{T}\\mathbf{y} + 2\\mathbf{R}^{T}\\mathbf{R}\\mathbf{x}\n$$\nSetting the gradient to zero for the optimal solution $\\hat{\\mathbf{x}}$:\n$$\n-2\\mathbf{R}^{T}\\mathbf{y} + 2\\mathbf{R}^{T}\\mathbf{R}\\hat{\\mathbf{x}} = \\mathbf{0}\n$$\nThis simplifies to the so-called normal equations:\n$$\n\\mathbf{R}^{T}\\mathbf{R}\\hat{\\mathbf{x}} = \\mathbf{R}^{T}\\mathbf{y}\n$$\nThis is the condition that characterizes the least-squares minimizer $\\hat{\\mathbf{x}}$.\n\nNext, we solve this system for $\\hat{\\mathbf{x}}$. First, we compute the matrix $\\mathbf{R}^{T}\\mathbf{R}$ and the vector $\\mathbf{R}^{T}\\mathbf{y}$.\n$$\n\\mathbf{R}^{T} = \\begin{pmatrix}\n8  7  2  1  0 \\\\\n2  6  7  2  1 \\\\\n0  1  3  8  7\n\\end{pmatrix}\n$$\n$$\n\\mathbf{R}^{T}\\mathbf{R} = \\begin{pmatrix}\n8  7  2  1  0 \\\\\n2  6  7  2  1 \\\\\n0  1  3  8  7\n\\end{pmatrix}\n\\begin{pmatrix}\n8  2  0 \\\\\n7  6  1 \\\\\n2  7  3 \\\\\n1  2  8 \\\\\n0  1  7\n\\end{pmatrix} = \\begin{pmatrix}\n118  74  21 \\\\\n74  94  50 \\\\\n21  50  123\n\\end{pmatrix}\n$$\n$$\n\\mathbf{R}^{T}\\mathbf{y} = \\begin{pmatrix}\n8  7  2  1  0 \\\\\n2  6  7  2  1 \\\\\n0  1  3  8  7\n\\end{pmatrix}\n\\begin{pmatrix}31 \\\\ 49 \\\\ 37 \\\\ 28 \\\\ 18\\end{pmatrix} = \\begin{pmatrix}\n8(31)+7(49)+2(37)+1(28)+0(18) \\\\\n2(31)+6(49)+7(37)+2(28)+1(18) \\\\\n0(31)+1(49)+3(37)+8(28)+7(18)\n\\end{pmatrix} = \\begin{pmatrix}\n248+343+74+28 \\\\\n62+294+259+56+18 \\\\\n49+111+224+126\n\\end{pmatrix} = \\begin{pmatrix} 693 \\\\ 689 \\\\ 510 \\end{pmatrix}\n$$\nThe normal equations are:\n$$\n\\begin{pmatrix}\n118  74  21 \\\\\n74  94  50 \\\\\n21  50  123\n\\end{pmatrix} \\hat{\\mathbf{x}} = \\begin{pmatrix} 693 \\\\ 689 \\\\ 510 \\end{pmatrix}\n$$\nThe matrix $\\mathbf{R}^{T}\\mathbf{R}$ is invertible as its determinant is non-zero ($\\det(\\mathbf{R}^{T}\\mathbf{R}) = 509714$), so a unique solution exists: $\\hat{\\mathbf{x}} = (\\mathbf{R}^{T}\\mathbf{R})^{-1}\\mathbf{R}^{T}\\mathbf{y}$. Solving this system of linear equations yields:\n$$\n\\hat{\\mathbf{x}} \\approx \\begin{pmatrix} 3.16333 \\\\ 3.72731 \\\\ 2.09113 \\end{pmatrix}\n$$\nNext, we compute the residual vector $\\mathbf{r} = \\mathbf{y} - \\mathbf{R}\\hat{\\mathbf{x}}$. First, we find the fitted spectrum $\\hat{\\mathbf{y}} = \\mathbf{R}\\hat{\\mathbf{x}}$:\n$$\n\\hat{\\mathbf{y}} = \\begin{pmatrix}\n8  2  0 \\\\\n7  6  1 \\\\\n2  7  3 \\\\\n1  2  8 \\\\\n0  1  7\n\\end{pmatrix}\n\\begin{pmatrix} 3.16333 \\\\ 3.72731 \\\\ 2.09113 \\end{pmatrix} \\approx \\begin{pmatrix}\n8(3.16333) + 2(3.72731) \\\\\n7(3.16333) + 6(3.72731) + 1(2.09113) \\\\\n2(3.16333) + 7(3.72731) + 3(2.09113) \\\\\n1(3.16333) + 2(3.72731) + 8(2.09113) \\\\\n0(3.16333) + 1(3.72731) + 7(2.09113)\n\\end{pmatrix} \\approx \\begin{pmatrix}\n32.7611 \\\\\n46.5982 \\\\\n38.6912 \\\\\n27.3470 \\\\\n18.3653\n\\end{pmatrix}\n$$\nThe residual vector is $\\mathbf{r} = \\mathbf{y} - \\hat{\\mathbf{y}}$:\n$$\n\\mathbf{r} \\approx \\begin{pmatrix}31 \\\\ 49 \\\\ 37 \\\\ 28 \\\\ 18\\end{pmatrix} - \\begin{pmatrix}\n32.7611 \\\\\n46.5982 \\\\\n38.6912 \\\\\n27.3470 \\\\\n18.3653\n\\end{pmatrix} = \\begin{pmatrix}\n-1.7611 \\\\\n2.4018 \\\\\n-1.6912 \\\\\n0.6530 \\\\\n-0.3653\n\\end{pmatrix}\n$$\nFinally, we compute the Euclidean norm of the residual, $||\\mathbf{r}||_{2}$:\n$$\n||\\mathbf{r}||_{2}^{2} = (-1.7611)^{2} + (2.4018)^{2} + (-1.6912)^{2} + (0.6530)^{2} + (-0.3653)^{2}\n$$\n$$\n||\\mathbf{r}||_{2}^{2} \\approx 3.10135 + 5.76864 + 2.86016 + 0.42641 + 0.13344 = 12.2900\n$$\n$$\n||\\mathbf{r}||_{2} \\approx \\sqrt{12.2900} \\approx 3.505708\n$$\nA more precise calculation, avoiding intermediate rounding, can be performed using the identity $||\\mathbf{r}||_{2}^{2} = ||\\mathbf{y}||_{2}^{2} - \\hat{\\mathbf{y}}^{T}\\hat{\\mathbf{y}} = ||\\mathbf{y}||_{2}^{2} - \\hat{\\mathbf{x}}^{T}(\\mathbf{R}^{T}\\mathbf{R})\\hat{\\mathbf{x}} = ||\\mathbf{y}||_{2}^{2} - \\hat{\\mathbf{x}}^{T}\\mathbf{R}^{T}\\mathbf{y}$.\n$||\\mathbf{y}||_{2}^{2} = 31^{2} + 49^{2} + 37^{2} + 28^{2} + 18^{2} = 961 + 2401 + 1369 + 784 + 324 = 5839$.\n$\\hat{\\mathbf{x}}^{T}\\mathbf{R}^{T}\\mathbf{y} \\approx (3.16333, 3.72731, 2.09113) \\begin{pmatrix} 693 \\\\ 689 \\\\ 510 \\end{pmatrix} \\approx 2192.39 + 2568.02 + 1066.48 = 5826.89$.\n$||\\mathbf{r}||_{2}^{2} \\approx 5839 - 5826.89 = 12.11$, which is slightly off due to rounding $\\hat{\\mathbf{x}}$. Using the exact fractional form of $\\hat{\\mathbf{x}}$ leads to $||\\mathbf{r}||_{2}^{2} \\approx 12.29008$, and thus $||\\mathbf{r}||_{2} \\approx 3.505721$.\nRounding to four significant figures, the norm is $3.506$.\n\nThe problem also asks for reasoning on the potential need for regularization.\nThe relative magnitude of the residual norm is $||\\mathbf{r}||_{2} / ||\\mathbf{y}||_{2} \\approx 3.506 / \\sqrt{5839} \\approx 3.506 / 76.41 \\approx 0.0459$, or about $4.6\\%$. This value is small but non-zero, suggesting the linear model is a good, but not perfect, fit for the data.\nThe need for regularization is often motivated by ill-conditioning of the matrix $\\mathbf{R}^{T}\\mathbf{R}$, which can be assessed by the correlation between the columns of $\\mathbf{R}$. The correlation between the first two columns of $\\mathbf{R}$ is approximately $0.703$. This indicates significant spectral overlap between the first two fluorophores. High correlation can make the solution $\\hat{\\mathbf{x}}$ sensitive to noise. While the condition number of $\\mathbf{R}^{T}\\mathbf{R}$ is not excessively large (around $15.5$), the combination of a non-zero model error (indicated by $||\\mathbf{r}||_{2}  0$) and spectral overlap suggests that regularization (e.g., Tikhonov regularization or imposing a non-negativity constraint on $\\mathbf{x}$) might yield a more physically meaningful and stable estimate of the fluorophore contributions, particularly in lower signal-to-noise ratio scenarios.", "answer": "$$\\boxed{3.506}$$", "id": "5031370"}, {"introduction": "A laboratory test result is only useful when we understand its predictive power in a real-world clinical setting, a concept crucial for accurate patient counseling. This exercise bridges the gap between abstract test performance metrics, such as sensitivity and specificity, and their practical implications. By applying Bayes' theorem to a prenatal FISH screening scenario, you will calculate the Positive and Negative Predictive Values (PPV and NPV), learning how the probability of disease changes after a test result is known.", "problem": "A prenatal laboratory uses fluorescence in situ hybridization (FISH) to rapidly enumerate chromosome 21 copy number in uncultured amniocytes for suspected trisomy 21. In a specific high-risk referral cohort, the following performance and population parameters are established from validation and epidemiologic data: sensitivity $\\text{Se} = 0.98$, specificity $\\text{Sp} = 0.995$, and disease prevalence (pre-test probability) $\\pi = 0.02$. Starting only from the definitions of sensitivity, specificity, disease prevalence, and Bayes' theorem relating pre-test to post-test probabilities, derive expressions for the positive predictive value (PPV) and negative predictive value (NPV) of this FISH assay, and then compute their numerical values for this cohort. Round both PPV and NPV to four significant figures and express them as decimals (do not use a percentage sign). Finally, briefly interpret how these values would affect prenatal counseling decisions and confirmatory testing strategies compared to the role of spectral karyotyping (SKY), while recognizing that SKY provides genome-wide color-coded chromosome identification but has different turnaround and target specificity. Your final submitted answer must include only the computed PPV and NPV as two entries in a single row matrix.", "solution": "The problem is deemed valid as it is scientifically grounded in the principles of medical diagnostic testing, well-posed with a complete and consistent set of parameters, and presented in objective, formal language. It requires the derivation and application of standard biostatistical formulas.\n\nLet us define the events for our analysis:\n- $D$: The event that the fetus has trisomy $21$ (the disease is present).\n- $D^c$: The event that the fetus does not have trisomy $21$ (the disease is absent).\n- $T^+$: The event that the fluorescence in situ hybridization (FISH) test result is positive.\n- $T^-$: The event that the FISH test result is negative.\n\nThe problem provides the following parameters, which we can express as probabilities:\n- The sensitivity of the test, $\\text{Se}$, is the probability of a positive test result given that the disease is present:\n$$ \\text{Se} = P(T^+ | D) = 0.98 $$\n- The specificity of the test, $\\text{Sp}$, is the probability of a negative test result given that the disease is absent:\n$$ \\text{Sp} = P(T^- | D^c) = 0.995 $$\n- The prevalence of the disease, $\\pi$, is the prior probability of having the disease in a given population:\n$$ \\pi = P(D) = 0.02 $$\n\nFrom these definitions, we can also determine related probabilities:\n- The probability of being disease-free is $P(D^c) = 1 - P(D) = 1 - \\pi = 1 - 0.02 = 0.98$.\n- The false positive rate is the probability of a positive test given the disease is absent: $P(T^+ | D^c) = 1 - P(T^- | D^c) = 1 - \\text{Sp} = 1 - 0.995 = 0.005$.\n- The false negative rate is the probability of a negative test given the disease is present: $P(T^- | D) = 1 - P(T^+ | D) = 1 - \\text{Se} = 1 - 0.98 = 0.02$.\n\nOur objective is to derive expressions for the Positive Predictive Value (PPV) and the Negative Predictive Value (NPV).\n\nThe PPV is the post-test probability of having the disease given a positive test result, defined as $P(D | T^+)$. We use Bayes' theorem to derive its expression:\n$$ \\text{PPV} = P(D | T^+) = \\frac{P(T^+ | D) P(D)}{P(T^+)} $$\nThe denominator, $P(T^+)$, is the total probability of obtaining a positive test result. We can expand it using the law of total probability:\n$$ P(T^+) = P(T^+ | D) P(D) + P(T^+ | D^c) P(D^c) $$\nSubstituting the terms for sensitivity, specificity, and prevalence:\n$$ P(T^+) = (\\text{Se})(\\pi) + (1 - \\text{Sp})(1 - \\pi) $$\nTherefore, the full expression for PPV is:\n$$ \\text{PPV} = \\frac{(\\text{Se})(\\pi)}{(\\text{Se})(\\pi) + (1 - \\text{Sp})(1 - \\pi)} $$\n\nThe NPV is the post-test probability of not having the disease given a negative test result, defined as $P(D^c | T^-)$. We again use Bayes' theorem:\n$$ \\text{NPV} = P(D^c | T^-) = \\frac{P(T^- | D^c) P(D^c)}{P(T^-)} $$\nThe denominator, $P(T^-)$, is the total probability of obtaining a negative test result. We expand it using the law of total probability:\n$$ P(T^-) = P(T^- | D^c) P(D^c) + P(T^- | D) P(D) $$\nSubstituting the terms for sensitivity, specificity, and prevalence:\n$$ P(T^-) = (\\text{Sp})(1 - \\pi) + (1 - \\text{Se})(\\pi) $$\nTherefore, the full expression for NPV is:\n$$ \\text{NPV} = \\frac{(\\text{Sp})(1 - \\pi)}{(\\text{Sp})(1 - \\pi) + (1 - \\text{Se})(\\pi)} $$\n\nNow, we compute the numerical values for PPV and NPV using the given parameters: $\\text{Se} = 0.98$, $\\text{Sp} = 0.995$, and $\\pi = 0.02$.\n\nFor the PPV:\n$$ \\text{PPV} = \\frac{(0.98)(0.02)}{(0.98)(0.02) + (1 - 0.995)(1 - 0.02)} = \\frac{0.0196}{0.0196 + (0.005)(0.98)} = \\frac{0.0196}{0.0196 + 0.0049} = \\frac{0.0196}{0.0245} = 0.8 $$\nRounding to four significant figures, we get $\\text{PPV} = 0.8000$.\n\nFor the NPV:\n$$ \\text{NPV} = \\frac{(0.995)(1 - 0.02)}{(0.995)(1 - 0.02) + (1 - 0.98)(0.02)} = \\frac{(0.995)(0.98)}{(0.995)(0.98) + (0.02)(0.02)} = \\frac{0.9751}{0.9751 + 0.0004} = \\frac{0.9751}{0.9755} $$\n$$ \\text{NPV} \\approx 0.9995899538698104... $$\nRounding to four significant figures, we get $\\text{NPV} = 0.9996$.\n\nFinally, a brief interpretation of these values and a comparison with spectral karyotyping (SKY) is required.\nA PPV of $0.8000$ indicates that for a patient in this high-risk cohort who receives a positive FISH result, there is an $80.00\\%$ probability that the fetus is actually affected with trisomy $21$. While this is a high probability, it also means there is a $20.00\\%$ chance the result is a false positive. This significant residual uncertainty makes it ethically and medically imperative to recommend a definitive, diagnostic confirmatory test, such as a full karyotype analysis from cultured amniocytes or chorionic villus sampling, before any irreversible clinical decisions (e.g., pregnancy termination) are considered.\nAn NPV of $0.9996$ is extremely high. It signifies that a negative FISH result is highly reassuring, with a $99.96\\%$ probability that the fetus is not affected by trisomy $21$. The post-test probability of having the disease despite the negative result is only $1 - 0.9996 = 0.0004$, or $1$ in $2500$. For most patients, this level of certainty is sufficient to rule out trisomy $21$, and no further invasive testing for this specific aneuploidy would be indicated.\nThe role of FISH is thus a rapid screening or preliminary test. Its main advantage is speed (results in $24-48$ hours), which reduces parental anxiety. However, it is targeted only to specific chromosomes. In contrast, spectral karyotyping (SKY), like conventional G-banded karyotyping, provides a comprehensive, genome-wide analysis of all chromosomes but requires cell culture and has a longer turnaround time ($1-2$ weeks). SKY is superior for detecting complex chromosomal rearrangements (e.g., translocations, insertions, deletions) that are invisible to a targeted FISH panel. Therefore, the strategy is to use FISH for rapid risk assessment. A positive FISH result mandates confirmation with a full karyotype (or SKY for complex cases) to ensure diagnostic accuracy and to assess the entire chromosome complement for abnormalities that FISH would miss. SKY acts as the gold-standard diagnostic tool, whereas FISH functions as a highly effective triage instrument.", "answer": "$$ \\boxed{\n\\begin{pmatrix}\n0.8000  0.9996\n\\end{pmatrix}\n} $$", "id": "5031352"}]}